Von Willebrand Disease&nbsp;
&nbsp;
Von Willebrand Disease (VWD) is a lifelong bleeding disorder in which your blood doesn't clot properly. People with the disease have low levels of von Willebrand factor, a protein that helps blood clot, or the protein doesn't perform as it should.
&nbsp;
Most people with the disease are born with it, having inherited it from one or both parents. Von Willebrand&rsquo;s disease can't be cured. But with treatment and self-care, most people with this disease can lead active lives.
&nbsp;
Von Willebrand Disease Epidemiology Segmentation in the United States&nbsp;
&nbsp;
<ul>
<li>Total Von Willebrand Disease diagnosed prevalent population</li>
<li>Gender-specific Von Willebrand Disease diagnosed prevalent population</li>
<li>Type-specific Von Willebrand Disease diagnosed prevalent population</li>
<li>Age-specific Von Willebrand Disease diagnosed as prevalent population&nbsp;</li>
</ul>
&nbsp;
<a style="color: #0047b2; background-color: transparent;" href="https://www.delveinsight.com/report-store/von-willebrand-disease-epidemiology-forecast" target="_blank" rel="noopener noreferrer">Von Willebrand Disease Epidemiological Insights</a> Observed in the United States&nbsp;(2020)
&nbsp;
<ul>
<li>The total diagnosed prevalent cases of Von Willebrand Disease was 12,505.</li>
<li>Females account for 55.50% of diagnosed prevalent cases of Von Willebrand Disease.</li>
<li>Gender-specific diagnosed prevalent populations of Von Willebrand Disease in males were observed to be 5,565 whereas in females it was found to be 6,941.</li>
</ul>
&nbsp;
<a style="color: #1155cc; background-color: transparent;" href="https://www.delveinsight.com/report-store/von-willebrand-disease-vwd-market" target="_blank" rel="noopener noreferrer">Von Willebrand Disease Market Insight</a>
&nbsp;
The market size of Von Willebrand Disease in the United States was found to be USD 309 million in 2020. &nbsp;
&nbsp;
Von Willebrand Disease Market Drivers
&nbsp;
<ul>
<li>Raising awareness</li>
<li>Regulatory approvals</li>
<li>Pediatric population</li>
</ul>
&nbsp;
Von Willebrand Disease Market Barriers
&nbsp;
<ul>
<li>Lack of robust pipeline</li>
<li>Diagnostic dilemma</li>
<li>Lack of assay for anti-VWF alloantibody&nbsp;</li>
</ul>
&nbsp;
Von Willebrand Disease Marketed Therapies
&nbsp;
The marketed drugs&nbsp;in the Von Willebrand Disease market are
&nbsp;
<ul>
<li>Vonvendi</li>
<li>Humate-P/Haemate P</li>
<li>Wilate</li>
<li>Desmopressin</li>
<li>Alphanate, and several others</li>
</ul>
&nbsp;
Von Willebrand Disease Key Players&nbsp;
&nbsp;
The key players working in the Von Willebrand Disease market are
&nbsp;
<ul>
<li>Shire</li>
<li>CSL Behring</li>
<li>Octapharma</li>
<li>Ferring Pharmaceuticals</li>
<li>Grifols Biological Inc., and several others</li>
</ul>
&nbsp;
Map the recent updates on <a style="background-color: transparent; color: #0047b2;" href="https://www.delveinsight.com/blog/von-willebrand-disease-vwd-market" target="_blank" rel="noopener noreferrer">Von Willebrand Disease Market Landscape</a> through our latest blog

Von Willebrand Disease Market

Von Willebrand Disease Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape 